Deferred Tax Assets and Liabilities (Tables)

6 Months Ended

Jun. 30, 2023

Income Tax Disclosure [Abstract]

Schedule Reconciliation of Statutory Income Tax Rate to Consolidated Effective Income Tax rate

A reconciliation of income tax expense at the federal statutory rate to the income tax provision at the Company's effective rate is as follows:

	Six Months Ended
	June 30, 2023			June 30, 2022
Income tax benefit at statutory rates	$	1,604,134		$	2,968,062
Valuation allowance for deferred tax assets		(1,625,391	)		(2,947,086	)
Stock-based compensation		(17,634	)		(12,642	)
Other benefit, net		25,719			(14,108	)
Reported income tax expense	$	(13,172	)	$	(5,774	)
Effective tax rate:		0.2	%		0.0	%

Schedule of Deferred Tax Assets and Liabilities

The Company’s deferred tax assets consisted of the following as of:

	June 30, 2023			December 31, 2022
Noncurrent deferred tax assets:
Net operating loss carryforwards	$	19,201,198		$	17,428,266
Intangible assets		2,163,563			2,382,397
Property and equipment		1,554,492			1,660,954
Research and development credits		348,427			300,105
Accrued expenses		866,024			766,385
Right of use asset		3,993			524
Bad debt allowance		33,736			20,282
Charitable contributions		40,782			38,557
Unexercised options		1,235,230			1,136,475
Capitalized research and development costs		242,052			194,320
Total noncurrent deferred tax assets		25,689,497			23,928,265
Valuation allowance		(25,689,497	)		(23,928,265	)
Total net deferred tax assets	$	—		$	—